SeaStar Medical Holding (ICU) Shares Outstanding (2020 - 2026)
SeaStar Medical Holding's (ICU) quarterly Shares Outstanding (Entity) came in at $4.0 million in Q1 2026, up 331.39% YoY from $925776.0 in Q1 2025, and up 92.65% on a QoQ basis from $2.1 million in Q4 2025.
SeaStar Medical Holding (ICU) Shares Outstanding (2020 - 2026) Analysis & Trends
SeaStar Medical Holding (ICU) has 7 years of Shares Outstanding (Entity) data on file, last reported at $4.0 million in Q1 2026.
- Quarterly Shares Outstanding (Entity) rose 331.39% year-over-year to $4.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.0 million (up 331.39% YoY) and the FY2025 annual result came in at $2.1 million, up 453.78% from the prior year.
- Shares Outstanding (Entity) rose to $4.0 million in Q1 2026, from $2.1 million in the prior quarter.
- In the past five years, Shares Outstanding (Entity) ranged from a high of $4.0 million in Q1 2026 to a low of $32845.0 in Q4 2022.
- A 5-year average of $742502.1 and a median of $301678.0 in 2024 frame the typical range for Shares Outstanding (Entity).
- Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) dropped 19.84% — and 2025, when it soared 526.27%.
- Tracing ICU's Shares Outstanding (Entity) over 5 years: stood at $32845.0 in 2022, then jumped by 163.91% to $86681.0 in 2023, then surged by 331.88% to $374355.0 in 2024, then jumped by 453.78% to $2.1 million in 2025, then surged by 92.65% to $4.0 million in 2026.
- The last three Shares Outstanding (Entity) figures came in at $4.0 million (Q1 2026), $2.1 million (Q4 2025), and $2.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 62.19 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 398.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 111.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 133.61 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 241.70 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 217.35 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 445.06 Mn |
| 10 | SeaStar Medical Holding | 13.68 Mn | 6.68 Mn | 561,000.00 | 4.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.92 Mn |
| Mar 31, 2026 | 3.92 Mn |
| Dec 31, 2025 | 2.07 Mn |
| Sep 30, 2025 | 2.64 Mn |
| Jun 30, 2025 | 1.13 Mn |
| Mar 31, 2025 | 861,793.00 |
| Dec 31, 2024 | 374,355.00 |
| Sep 30, 2024 | 408,687.00 |
| Jun 30, 2024 | 315,478.00 |
| Mar 31, 2024 | 268,424.00 |
| Dec 31, 2023 | 86,681.00 |
| Sep 30, 2023 | 80,194.00 |
| Jun 30, 2023 | 59,731.00 |
| Mar 31, 2023 | 52,103.00 |
| Dec 31, 2022 | 32,845.00 |
| Sep 30, 2022 | 41,814.00 |
| Jun 30, 2022 | 41,814.00 |
| Mar 31, 2022 | 41,814.00 |
| Dec 31, 2021 | 38,606.00 |
| Sep 30, 2021 | 41,814.00 |